Please assess the completion status of the following clinical trial:

Trial Title: A Trial of INO-1001 in Patients Undergoing Heart Surgery That Involves Heart-lung Bypass

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients scheduled to undergo cardiopulmonary bypass for coronary revascularization and/or valve surgery~* Males and non-pregnant, non-lactating females~Exclusion Criteria:~* Subjects will be required to undergo a full medical review in order to exclude serious medical or psychological illness prior to inclusion~* History of a hypersensitivity reaction to more than three drugs or to mannitol~* Participation in any other investigational study within 30 days of the screening phase~* Known alcohol or drug abuse within the last year~* Treatment with certain restricted medications within a specified time prior to participation in the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).